Specialty Pharma Journal Specialty, Precision & Technology
Crohn’s disease – a type of inflammatory bowel disease – affects three-quarters of a million Americans. The causes underlying Crohn’s have been murky, but new research is adding some clarity to this disease. An international research team led by the Case Western Reserve University School of Medicine recently announced that …
Tag Archives: Crohn’s
October, 2016
-
17 October
Celgene Announces Results from Early-Stage Study of Investigational Crohn’s Disease Pill
VIENNA–(BUSINESS WIRE)–Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluating the effects of investigational oral GED-0301 (mongersen) 160 mg on both endoscopic response and clinical remission in patients with active Crohn’s disease will be presented in …
March, 2016
-
18 March
Janssen’s Stelara Achieves Primary Endpoint in its Late-Stage Crohn’s Trial
AMSTERDAM, March 18, 2016 /PRNewswire/ — Phase 3 data presented at the 11th Congress of the European Crohn’s and Colitis Organisation (ECCO) showed that treatment with STELARA® (ustekinumab) induced clinical response and clinical remission in adult patients with moderate to severe Crohn’s disease who had previously failed or were intolerant to …